We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Oxycodone

News List

J&J faces $2bn insurance fraud charges over opioid claims pharmaceutical-technology
September 21, 2020
The New York State Department of Financial Services (DFS) has filed a $2bn lawsuit against Johnson & Johnson (J&J) for its alleged role in the opioid crisis in the US.
Health Highlights drugs
May 08, 2019
The number of legally prescribed opioid pain drugs stolen by health care workers in the United States rose 126% between 2017 and 2018, a new report says.
FDA rejects Mallinckrodt’s abuse-deterrent form of Roxicodone pharmatimes
December 13, 2018
Mallinckrodt's SpecGx division has announced the rejection of its abuse-deterrent re-formulation of opioid analgesic Roxicodone by the US Food and Drug Administration (FDA).
Lannett Receives FDA Approval for Oxycodone, Acetaminophen Tablets americanpharmaceuticacreview
September 28, 2017
Our planned product launches, combined with our on-going integration and cost reduction efforts, are just some of the factors that give us confidence Lannett's future is bright."